Know Cancer

or
forgot password

Endoscopic Therapy of Early Cancer in Barretts Esophagus


Phase 2
18 Years
N/A
Not Enrolling
Both
Early Stage Esophageal Adenocarcinoma, Barrett Esophagus

Thank you

Trial Information

Endoscopic Therapy of Early Cancer in Barretts Esophagus


Participant visit requirements: Screening visit which will last 1 - 2 days, if assigned to
photodynamic therapy, there will be a 3 day visit for treatment. Participants must return
for a 1 day visit every three months for one year.

Inclusion Criteria


Early esophageal cancer in Barrett's Esophagus in patients not eligible for surgical or
radiological therapy. Participants must be have oral intake of greater than 1700 calories
a day. No history of prior cancer within the past 5 years. And have no history of
extensive prior esophageal surgery (example: esophagectomy)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To examine whether photodynamic therapy in addition to endoscopic mucosal resection will decrease cancer recurrence in early esophageal adenocarcinoma

Outcome Time Frame:

end of study

Safety Issue:

No

Principal Investigator

Kenneth K. Wang, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

1399-05

NCT ID:

NCT00217087

Start Date:

September 2005

Completion Date:

June 2012

Related Keywords:

  • Early Stage Esophageal Adenocarcinoma
  • Barrett Esophagus
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Barrett Esophagus
  • Esophageal Diseases

Name

Location
Mayo Clinic Rochester, Minnesota  55905